Showing posts with label gsk. Show all posts
Showing posts with label gsk. Show all posts

Monday, November 7, 2011

Warren Buffett Invested $23.9 Billion for the Latest Quarter

Warren Buffett, chairman and CEO of Berkshire Hathaway (BRK-A) (BRK-B) and the third richest man in the world, at least this week, invested $23.9 billion during the third quarter. Apparently, Buffett is now very bullish as this is the most he has spent in a quarter in the last 15 years. According to the Berkshire's latest report, stocks identified as “commercial, industrial and other” increased by a substantial 62 percent for the latest quarter.

There is no denying that Warren Buffett is an outstanding investor, and he knows what he is doing. Much has been written about Buffett, which gives advice about how to invest by following in his footsteps. But one of the easiest and best ways to invest like Buffett is by buying what he is buying. Over a dozen of the Warren Buffett Berkshire Hathaway stocks pay dividend yields in excess of 2%, according to WallStreetNewsNetwork.com.

Buffett has a fairly diversified portfolio. He owns large oil companies, ConocoPhillips (COP) yielding 3.5% and Exxon Mobil Corp. (XOM) which pays a yield of 2.1%. He also owns food and beverage companies, including Kraft Foods Inc (KFT) paying 3.8% and Coca Cola Co (KO) which pays 2.7%. Buffett is also bullish on financial stocks, considering the number of companies he owns, such as M&T Bank Corp (MTB) yielding 3.1%, American Express Co (AXP) 1.6%, Bank of New York Mellon (BK) 1.2%, US Bancorp (USB) 0.7%, and Wells Fargo & Co (WFC) 0.6%.

The health care related stocks owned by Buffett include GlaxoSmithKline Plc (GSK) which yields 6.4%, Johnson & Johnson (JNJ) 3.6%, and Sanofi Aventis (SNY) 3.2%.

You can access a free list of two dozen of the stocks owned by Warren Buffett at WallStreetNewsNetwork.com, which shows the PE ratio, the forward PE, the EG, and the yield.

Disclosure: Author didn't own any of the above at the time the article was written.


By Stockerblog.com

Thursday, June 23, 2011

High Yield Big Pharmaceutical Stocks

Between 1945 and 1964, seventy-six million American babies were born, making up what is now known as the Baby Boomers. The Boomers buy 77% of all prescription drugs and 61% of over-the-counter medications.

Many income investors are looking for dividend stocks in the health care sector due to the increasing age of the Baby Boomers and their parents. These include the major drug manufacturers, the generic drug manufacturers, diagnostic companies, healthcare plans, hospitals, medical appliances, medical instruments, and medical laboratories.

Based on the free list of high yield big pharmaceutical stocks at WallStreetNewsNetwork.com, there are ten pharmaceutical stocks with yields of 1.5% or more, with two stocks paying more than 5%. One example is GlaxoSmithKline plc (GSK), the third largest pharmaceutical company in the world by revenues, after Johnson & Johnson (JNJ) and Pfizer(PFE). Glaxo's products include Aquafresh, Boniva, Dexedrine, Levitra, Nicoderm, Nicorette, Sensodyne, Tums, and Valtrex. The stock pays a generous yield of 5.1% payable quarterly. It trades at 10.5 times forward earnings. Although sales were down for the latest quarter, earnings were up 13.8% year over year.

Johnson & Johnson (JNJ), the world's largest pharma company, is a manufacturer of pharmaceutical, medical devices and consumer packaged goods. The company, which was founded in 1886, yields 3.4% and has a forward price to earnings ratio of 12.4. Revenues for the latest quarter were up 3.4% but earnings were down 23.2%.

Merck & Co., Inc. (MRK), another big pharmaceutical, yields 4.2% and trades at 9.1 times forward earnings. Earnings for the latest quarter were up almost 250% on flat revenues.

If you want a list of other high yield pharma stocks, that can be downloaded and sorted, go to WallStreetNewsNetwork.com.

Disclosure: Author owns PFE.

By Stockerblog.com